Model
Edge
BioCryst Pharmaceuticals Inc
0001718020
Filing Type
144
Filing Date
6/16/2024
Updated
6/17/24, 2:14 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities